Anti-streptavidin antibodies as a cause of false-positive results of streptavidin-based autoantibody assays

Christoph Robier
  • Corresponding author
  • Institute of Laboratory Diagnostics, Hospital of the Brothers of St. John of God, Bergstr. 27, 8020 Graz, Austria
  • Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz, Graz, Austria
  • Email
  • Search for other articles:
  • degruyter.comGoogle Scholar
, Norbert Kolbus and Ulrike Demel

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1.

    Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem 1999;45:942–56.

  • 2.

    Rulander NJ, Cardamone D, Senior M, Snyder PP, Master SR. Interference from anti-streptavidin antibody. Arch Pathol Lab Med 2013;137:1141–6.

  • 3.

    Piketty M-L, Polak M, Flechtner I, Gonzales-Briceno L, Souberbielle J-C. False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences. Clin Chem Lab Med 2017;55:780–8.

  • 4.

    Favresse J, Lardinois B, Nassogne MC, Preumont V, Maiter D, Gruson D. Anti-streptavidin antibodies mimicking heterophilic antibodies in thyroid function tests. Clin Chem Lab Med 2018;56:e160–3.

  • 5.

    Berth M, Willaert S, De Ridder C. Anti-streptavidin IgG antibody interference in anti-cyclic citrullinated peptide (CCP) IgG antibody assays is a rare but important cause of false-positive anti-CCP results. Clin Chem Lab Med 2018;56:1263–8.

  • 6.

    Duhn PH, Skovsted T, Kristensen B, Locht H. Development of IgG antibodies to streptavidin may explain a case of false-positive autoantibody screening test for connective tissue disease (CTD). Scand J Rheumatol Suppl 2014;43:81.

  • 7.

    Bayart J-L, Favresse J, Melnik E, Lardinois B, Fillée C, Maiter D, et al. Erroneous thyroid and steroid hormones profile due to anti-streptavidin antibodies. Clin Chem Lab Med 2019;57:e255–8.

  • 8.

    Holmes EW, Samarasinghe S, Emanuele MA, Meah F. Biotin interference in clinical immunoassays: a cause for concern. Arch Pathol Lab Med 2017;141:1459–60.

  • 9.

    Favresse J, Burlacu MC, Maiter D, Gruson D. Interferences with thyroid function immunoassays: clinical implications and detection algorithm. Endocr Rev 2018;39:830–50.

  • 10.

    Sztefko K. Human natural antibodies and immunoassay. In: Sonntag O, Plebani M, editors. Immunodiagnostics and patient safety. Berlin: De Gruyter, 2011:43–52.

  • 11.

    Dahll LK, Haave EM, Aas FE, Dahl SR, Thorsby PM. Effect of anti-streptavidin interference when diagnosing thyroid disease using immunoassay analyses. Endocr Abstracts 2019;63:GP181. DOI:10.1530/endoabs.63.GP181.

Purchase article
Get instant unlimited access to the article.
Price including VAT
Log in
Already have access? Please log in.

Journal + Issues

Clinical Chemistry and Laboratory Medicine ( CCLM) publishes articles on novel teaching and training methods applicable to laboratory medicine. CCLM welcomes contributions on the progress in fundamental and applied research and cutting-edge clinical laboratory medicine. It is one of the leading journals in the field, with an impact factor of over three. CCLM is the official journal of nine national clinical societies and associated with EFLM.